Industry Workshop by GE HealthCare
Mustafa Erkin Aribal, Istanbul / Turkey
Join this session to explore the role of Automated Breast Ultrasound (ABUS) in breast cancer screening. Learn how ABUS, both as a standalone modality and a complement to Digital Mammography, enhances the detection of invasive, biologically significant cancers compared to traditional 2D mammography. We will discuss its potential as a primary screening tool in areas where mammography is not accessible, with a focus on managing recall rates. Gain valuable insights into ABUS’s clinical utility, its advantages over conventional methods, and its effective incorporation into screening programs for improved patient outcomes.